Skip to main content
Clinical Trials/ITMCTR2000004159
ITMCTR2000004159
Recruiting
Phase 4

A multi-center real-world clinical research program for the application of Motherwort injection in the field of family planning after the market

He'nan Provincial People's Hospital0 sitesTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Abortion, placement or removal of an IUD
Sponsor
He'nan Provincial People's Hospital
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Observational study
Sex
Female

Investigators

Sponsor
He'nan Provincial People's Hospital

Eligibility Criteria

Inclusion Criteria

  • 1\. After induced abortion
  • Women of childbearing age who were diagnosed with pregnancy and required abortion were selected as the subjects of the study. And meet the following criteria:
  • 1\) Women eligible for induced abortion;
  • 2\) Aged18\-40 years old, in good health in the past;
  • 3\) Can fill in the bleeding card;
  • 4\) Volunteer for the study.
  • (2\) After placing the IUD
  • Women of childbearing age who were selected for IUD placement were studied. And meet the following criteria:
  • 1\) If the IUD is selected and placed as a long\-term contraceptive method, or vaginal bleeding \>\=8 days after the PLACEMENT of the IUD;
  • 2\) Can fill in the bleeding card;

Exclusion Criteria

  • 1\) Allergy to this product or excipients listed in motherwort preparation and ingredients or history of serious adverse reactions;
  • 2\) Patients with allergic constitution (allergic to motherwort or to motherwort preparation) \+ pregnant women;
  • 3\) Patients whom the researcher considers inappropriate.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
CLINICAL RESEARCH PROJECT ON A MULTI-CENTRE RANDOMIZED DOUBLE-BLIND PLACEBO CONTROLLED IN PARALLEL GROUPS STUDY TO EVALUATE THE EFFECTIVENESS SAFETY AND TOLERABILITY OF TIORFAN 1.5 MG / KG BODY WEIGHT ADMINISTERED 3 TIMES PER DAY ORALLY JOINTLY WITH ORAL REHYDRATION TREATMENT VERSUS PLACEBO IN CONJUNCTION WITH ORAL TREATMENT OF REHYDRATION IN THE TREATMENT OF ACUTE DIARRHEA IN CHILDREN.-K591 Functional diarrhoeaFunctional diarrhoeaK591
PER-031-99SMITHKLINE BEECHAM INTERAMERICAN,
Recruiting
Not Applicable
A multicenter, patient-control exploratory clinical trial for the clinical efficacy and safety assessment of a virtual reality-based cognitive assessment software (VARABOM-Diagnosis), aimed at assisting the mild cognitive impairment (MCI) screening diagnosis through cognitive function evaluation in patients with MCI.Mental and behavioural disorders
KCT0009132Yonsei University Health System, Gangnam Severance Hospital84
Not yet recruiting
Phase 2
Efficacy of tREating aSymptomatic infEctions To resTore fERtility: The RESETTER StudyInfertilityReproductive Health and Childbirth - Fertility including in vitro fertilisation
ACTRN12624001180505University of Western Australia440
Completed
Not Applicable
A multicenter study to examine clinical scenarios for long-term monitoring of epileptic seizures with a wearable biopotential technologyG40.2Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
DRKS00025547Department of Neurology, UZ Leuven495
Recruiting
Not Applicable
Multicenter and Prospective Clinical Study for the Development of Multi-Omics-Based Biomarkers in Acute Myeloid LeukemiaDiseases of the blood and blood -forming organs and certain disorders involving the immune mechanism
KCT0004825Chonnam National University Hospital Hwasun Hospital620